Related Experiment Video
Updated: Feb 5, 2026

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
RBM15 Enhances 5-Fluorouracil Drug Sensitivity and Suppresses Gastric Cancer Progression by Modulating
Xingyu Zhu1,2,3, Hao Chen4,5, Kang Xu6
1Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.
High RBM15 expression predicts better gastric cancer prognosis and suppresses tumor growth. RBM15 enhances chemosensitivity by regulating the IGF2BP3-ECT2 axis via m6A methylation.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Gastric cancer (GC) is a major global health concern with high mortality rates.
- Identifying prognostic biomarkers and therapeutic targets is crucial for improving GC outcomes.
Purpose of the Study:
- To investigate the role of RNA-binding motif protein 15 (RBM15) in gastric cancer.
- To elucidate the molecular mechanisms underlying RBM15's function and its impact on chemosensitivity.
Main Methods:
- Analysis of clinical tissues and public datasets (TCGA, ACRG, etc.).
- In vitro and in vivo functional assays.
- RNA sequencing, bioinformatics analysis, MeRIP, RIP-qPCR, RNA pull-down, and luciferase reporter assays.
- Animal and patient-derived organoid models.
Main Results:
- High RBM15 expression correlates with favorable prognosis in GC patients.
- RBM15 suppresses GC cell proliferation, migration, and invasion.
- RBM15 targets the oncogene ECT2 via m6A methylation, modulating its interaction with IGF2BP3.
- RBM15 enhances GC sensitivity to 5-fluorouracil (5-FU) chemotherapy.
Conclusions:
- A novel RBM15/IGF2BP3-ECT2 signaling axis regulates epithelial-mesenchymal transition (EMT) and chemosensitivity in GC.
- This axis functions through m6A methylation of ECT2 mRNA.
- RBM15 represents a potential therapeutic strategy for enhancing GC chemosensitivity.
Related Concept Videos
Drug Dependence
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...

